☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Anticipates
EMA Anticipates the EC's Conditional Marketing Authorization for Gilead's Remdesivir in Coming Week
June 26, 2020
Sanofi Anticipates the Approval of its COVID-19 Vaccine by First Half of 2021
June 24, 2020
Celltrion Anticipates the Launch of its POCT Kit for COVID-19 in July 2020
June 16, 2020
Celltrion Anticipates the Launch of Insulin Pen Biosimilar by 2025
June 3, 2020
Moderna Anticipates the Initiation of P-III Study of mRNA-1273 for COVID-19 by Early Summer
May 8, 2020
Regeneron Anticipates the Initiation of Clinical Study for its COVID-19 Antibody Cocktail in June
May 6, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.